Condensed Statement Of Cash Flows	4 Months Ended
	Sep. 30, 2020 USD ($)
Cash Flows from Operating Activities:
Net loss	$ (59,514)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account	(15,961)
Unrealized loss on securities held in Trust Account	14,209
Changes in operating assets and liabilities:
Prepaid expenses	(368,756)
Accrued expenses	15,000
Net cash used in operating activities	(415,022)
Cash Flows from Investing Activities:
Investment of cash into Trust Account	(200,000,000)
Net cash used in investing activities	(200,000,000)
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid	196,000,000
Proceeds from sale of Private Placement Warrants	6,000,000
Proceeds from promissory note—related party	126,005
Repayment of promissory note—related party	(126,005)
Payment of offering costs	(487,531)
Net cash provided by financing activities	201,512,469
Net Change in Cash	1,097,447
Cash – Beginning
Cash – Ending	1,097,447
Non-Cash Investing and Financing Activities:
Initial classification of ordinary shares subject to possible redemption	189,422,360
Change in value of ordinary shares subject to possible redemption	(54,511)
Deferred underwriting fee payable	7,000,000
Deferred offering costs paid directly by Sponsor from proceeds from issuance of ordinary shares	25,000
Offering costs included in accrued offering costs	$ 85,100